Previously, we found that the Insulin-Like Growth Factor Binding Protein-3, IGFBP-3, blocks HA-CD44 interactions by binding to HA, leading to decreased survival of A549 (p53 wild-type) lung cancer cells50. The gene discussed is CD44; the disease is lung carcinoma.